According to Acasti Pharma 's latest financial reports the company's current EPS (TTM) is -$5.64. In 2022 the company made an earnings per share (EPS) of -$2.34 an increase over its 2021 EPS that were of -$2.38.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$5.64 | 141.14% |
2022 | -$2.34 | -1.75% |
2021 | -$2.38 | -179.35% |
2020 | $3.00 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Omeros Corporation OMER | $0.64 | -111.35% | ๐บ๐ธ USA |